Read Dan’s article published in the MGMA of New York’s e-newsletter, outlining prior authorization as a growing concern for physician practices.
Managing the Challenges Associated with Prescription PAs
By Dan Rubin, New York MGMA
By Dan Rubin, New York MGMA
Read Dan’s article published in the MGMA of New York’s e-newsletter, outlining prior authorization as a growing concern for physician practices.
IN THE NEWS: The recent PARx PASS upgrades have appeared in the July 2017 issues of Ophthalmic Professional and Optometric Management.
June 5, 2017 (PRIMARY CARE OPTOMETRY NEWS) — PARx Solutions, a company that helps eye care prescribers get prior authorizations from insurance companies, has upgraded its platform by adding features to better aid prescribers, according to information from PARx Solutions. Read Article
Pharmaceutical Executive | Dan Rubin | May 4, 2017
Talk with busy physicians and you’ll soon hear about the ever-increasing difficulty in getting approval for the medications that they believe are most appropriate for their patients. For pharma marketers, a superior efficacy, side effect and dosing profile is a necessary start, and a favorable managed care formulary position can be another positive step toward commercial success—but, more and more frequently, a prior authorization (PA) request must be approved before a medication can be dispensed and taken by the patient. Read Article